NVAX - What's Going On With Novavax Shares Monday? | Benzinga
Novavax, Inc. (NASDAQ:NVAX) shares are moving higher on Monday. Here’s what you need to know.
What To Know: The company announced on July 2 that it has filed for authorization with Health Canada for its updated 2024-2025 protein-based COVID-19 vaccine (NVX-CoV2705) for individuals aged 12 and older. If approved, this would be the only protein-based COVID-19 vaccine option available in Canada. Novavax's updated vaccine targets the JN.1 variant and has shown broad neutralization responses against multiple ...